Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 23 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

61%

14 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
13(61.9%)
Phase 1
7(33.3%)
Phase 4
1(4.8%)
21Total
Phase 3(13)
Phase 1(7)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT07198347Phase 3Not Yet Recruiting

Efficacy and Safety of AG2001 in Patients With Acute Bronchitis

Role: lead

NCT07083206Recruiting

A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

Role: lead

NCT06916169Phase 1Not Yet Recruiting

A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042

Role: lead

NCT06717360Phase 3Not Yet Recruiting

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R

Role: lead

NCT06549504Phase 1Not Yet Recruiting

Bioequivalence Study of AG2202

Role: lead

NCT05503953Phase 3Unknown

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS

Role: lead

NCT05344638Phase 3Completed

A Clinical Trial to Evaluate the Safety and Efficacy of "AG1904" in Acute Bronchitis

Role: lead

NCT05206578Phase 3Unknown

Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

Role: lead

NCT04686643Phase 3Unknown

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

Role: lead

NCT04554303Unknown

Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension

Role: lead

NCT03623282Phase 4Completed

Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD

Role: lead

NCT01982916Phase 3Completed

Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

Role: lead

NCT02614352Phase 1Unknown

Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects

Role: lead

NCT01536353Phase 1Completed

Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301

Role: lead

NCT02609711Phase 1Unknown

Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects

Role: lead

NCT02274961Phase 3Unknown

S-pantoprazole 10mg Phase III Clinical Study

Role: lead

NCT01882296Phase 1Unknown

Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects

Role: lead

NCT01821521Phase 1Unknown

Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects

Role: lead

NCT01400945Phase 3Completed

Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease

Role: lead

NCT01416480Phase 3Completed

Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher

Role: lead